AngioDynamics ANGO has been gaining from its solid prospects with NanoKnife and an increased focus on cancer treatment ...

Beyond administering CAR T-cell therapy and bispecifics, oncology nurses must apply proactive, supportive care and an understanding of complex treatments.

Mesutoclax is a novel, orally bioavailable BCL2 selective inhibitor. BCL2 is an important regulatory protein in the apoptosis pathway, and its abnormal expression is associated with the development of ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the ...

TEL AVIV, Israel (AP) — Israel gave final approval Wednesday for a controversial settlement project in the occupied West Bank ...

Can BTK inhibitors finally move the needle in progressive MS? Dr Robert Fox joins Dr Anne Cross to unpack the results of the ...

Air Canada has resumed operations but it will be days before the backlog of flight cancellations are cleared. Many passengers ...

WICHITA, Kan. (KWCH) - On August 18, 2005, 20 years ago, a Sedgwick County judge sentenced Dennis Rader, also known as the ...

The Canada Industrial Relations Board had declared the strike illegal earlier on Monday and ordered the striking flight ...

TREMONTON, Utah (AP) — Two police officers were shot and killed in a northern Utah city and a man was taken into custody, ...

The professor who once taught Bryan Kohberger is still haunted by his crimes and wants answers the court never uncovered.

CLL-314 trial compared the efficacy and safety of pirtobrutinib with ibrutinib in adults with CLL/SLL who were treatment-naïve or who were previously treated and were BTK inhibitor-naïve.